K2 / RESORBIA

Transform a medical innovation into a global business with $40M+ valuation

RU

CASE⁰¹

Resorbia — a med-tech company that developed and patented resorbable (degradable) magnesium implants

Resorbable implants dissolve naturally in the body, eliminating repeat surgeries for trauma patients

рROBLEM⁰²

To launch production, company needed $10M+ investment and years for clinical trials, regulatory approvals, and manufacturing setup

Currently just a research project with patented technology. No revenue, no operations, no commercial structure

Investors don't fund "science projects" — they fund proven businesses with clear paths to market

CHALLENGE⁰³

How to turn a research project into a real business that can raise $10M+ from investors?

SOLUTION⁰⁴

Create a step-by-step funding plan and prepare the company for investment

PROCESS⁰⁵

Split $10M fundraising into three stages tied to clear milestones — reducing risk for investors at each step

Implement financial controls and operational management systems — K2 partner took hands-on role controlling budgets, accountability, and business KPIs

Secure company registration in Abu Dhabi medical cluster with government support — positioning for Middle East market entry

Package the technology story: completed trials, patents, 40+ products — transforming "research" into "investment-ready business"

Target angel investors for first $450K to prove the concept, then approach venture funds for remaining $9.5M once traction is demonstrated

RESULT⁰⁶

+$10M

capital commitment secured

UAE

medical cluster registration achieved

$300M

strategic exit valuation targeted

CAPABILITIES & SERVICES⁰⁸

Multi-stage fundraising strategy and investor targeting

Investment materials: pitch decks, financial models, and market positioning

International business structuring and special economic zone registration

Full operational management: budgets, controls, and accountability systems

Strategic exit planning and valuation modeling

PROJECT TEAM⁰⁷

MARGARITA KELLERMAN

Business Structuring

MICHAEL WEIHL

M&A Expertise

IGOR KRIVETSKY

Financial Modelling